We also used primary culture of ESCC cells models, as well as the KYSE-150 in vitro and in vivo models, to validate the efficacy of iPSC CD276-targeted CAR-NK cells against CD276-expressing human ESCC. The gene discussed is CD276; the disease is esophageal squamous cell carcinoma.